Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > As s1i has highlighted several times here
View:
Post by mdjbrown on Nov 07, 2023 9:26am

As s1i has highlighted several times here

Why didnt Medipharm announce this strategic partnership with Avicanna to the world back in June?

https://www.avicanna.com/avicanna-and-medipharm-labs-expand-strategic-manufacturing-agreement-for-avicannas-proprietary-sedds-technology-capsules-for-canadian-and-international-markets/

It was a big deal in 2020, so why not now

Almost as if the folks at Labs are doing their best to stay of the radar, but why is that?
Comment by subaru1 on Nov 07, 2023 11:46am
They had signed a contract for 3 years in may 2020, they is just a continuty of the agreement of 2020, and the 2023 agreement won't change anything for Labs. I don't see any other raison. There is no raison to keep a good news, any company that respect his shareholder will published a good news that will have a positive impact on the results of the company. The 3qrt result coming next week ...more  
Comment by subaru1i on Nov 07, 2023 11:49am
Your commentary on the new 2023 agreement between LABS and Avicanna are incorrect.   The PR from AVCN clearly stated: 1) expanded strategic manufacturing agreement (higher volumes? more sku's? or both?) 2) Technology integration of SEDDS for AVCN as well as for LABS.   So in summary, it is not at all "just a continuity of the agreement of 2020".    ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities